click below
click below
Normal Size Small Size show me how
Diuretics (Ziance)
Pharm Y2B3
| Question | Answer |
|---|---|
| thiazide | MOA: early distal tubule - inc flow of Na and H2O downstream segments of DT |
| thiazide | PT: Cl/Na channel - dec in Na reabsorption |
| thiazide | ADR: impotence, hyponatremia, hemolytic anemia |
| thiazide | hydrocholorothiazide |
| thiazide | chlorthalidone |
| thiazide | indapamide |
| loop diuretic | MOA: ascending loop - inhibit Na/K/Cl cotransporter; DT and CD will NOT reabsorb extra Na and Cl |
| loop diuretic | MOA: second site - inhibit Na reabsorb into interstitial fluid |
| loop diuretic | MOA: third site - weak inhibition of CA |
| loop diuretic | ADR: ototoxicity/nephrotoxicity; severe dehydration |
| loop diuretic | furosemide |
| loop diuretic | bumetanide |
| loop diuretic | torsemide |
| loop diuretic | ethacrynic acid |
| K sparring agent | MOA: block Na channel in lumen, therefore less K diffusion in lumen |
| K sparring agent | amiloride |
| K sparring agent | triamterene |
| aldosterone receptor blocker | MOA: CT - inhibit Na/H2O reabsorb. only takes several days |
| aldosterone receptor blocker | ADR: gynecomastia |
| aldosterone receptor blocker | spironolactone |
| CA inhibitor | acetazolamide |
| CA inhibitor | dorzolamide |
| osmotic diuretics | 4 MOA sites: pretty much prevents osmosis, even reduces efficiency of Na/K/Cl cotransporter |
| osmotic diuretics | ADR: worsening of CHF/pulmonary edema, reversible ARF |
| osmotic diuretic | mannitol |
| combo therapy | K-sparring + thiazide |
| K sparring agent | ADR: reduce GLU tolerance, photosensitivity |